Survivin在原发性肝细胞癌中的表达及其临床意义

目的 探讨Survivin在原发性肝细胞癌(HCC)组织中的表达及其在肝癌发病机制中的作用和临床意义.方法 利用免疫组织化学S-P法检测50例原发性肝癌组织、20例正常肝组织中Survivin蛋白表达情况.结果 Survivin蛋白在肝癌中的阳性表达率为66.0%(33/50),显著高于正常肝组织组(均为阴性表达;P<0.001),阳性表达与肝癌的肝内转移和肝癌的多发性有关(P=0.019,P=0.030);Survivin的过表达与病人术后<3年生存期相关(P=0.018).结论 Survivin在肝细胞癌的发生及发展过程中起着不同程度的作用,检测Survivin对判定原发性肝细胞癌预后可提供一定的依据.

Expression and clinical significance of survivin in primary hepatocellular carcinoma

Objective To investgate the expression and the clinical significance of survivin in the primary hepatocellular carcinoma (HCC). Methods S-P immunohistochemical staining was performed to detect the expression of survivin in 50 samples of HCC tissue and 20 of normal liver tissue. Results The positive rate of survivin expression in HCC was 66. 0% (33/50) , which was significantly higher than that in normol liver tissues (negative expression) (P<0. 001). The expression of survivin was correlated with intrahepatic dissemination and multiple masses (P = 0. 019, P=0. 030). The high survivin expression was associated with the survival time less than three years(P = 0. 018). Conclusion The survivin may play certain roles in the oncogenesis and progression of HCC. Detection of the survivin can supply certain evidence on prognosis of primary hepatocellular carcinoma.